Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Llewellyn-Thomas, H. A.
Right arrow Articles by Thiel, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Llewellyn-Thomas, H. A.
Right arrow Articles by Thiel, E. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cancer Patients' Decision Making and Trial-entry Preferences

The Effects of "Framing" Information about Short-term Toxicity and Long-term Survival

Hilary A. Llewellyn-Thomas, PhD

M. June McGreal, MEd

Elaine C. Thiel, BScN

The study purpose was to determine whether the framing of treatment information influenced patients' reported preferences for participating in treatment decision making and for trial entry. Ninety cancer patients read either neutrally-, positively-, or negatively-framed infor mation about a chemotherapeutic treatment, then indicated their preferences for participating in the treatment decision, and whether they would participate in a clinical trial incorporating this protocol. There was no difference across information groups in preferences for partici pating in treatment decision making or willingness to enter such a clinical trial. Preference for participation in treatment decision making was significantly related to age (t = 2.54; p = 0.022), sex (x2 = 3.89; p = 0.05), and education (t = 2.54; p = 0.018); trial entry preferences were unrelated to these demographic variables. These results imply that, in this clinical context, attitudes towards participation in treatment decision making may be asso ciated with characteristics of the patient, and attitudes towards trial entry may be dependent upon the clinical characteristics of a particular trial, but neither set of attitudes is influenced by the framing of protocol information. Key words: framing effect; patients' preferences; quality of life; decision making; clinical trials. (Med Decis Making 1995;15:4-12)

Medical Decision Making, Vol. 15, No. 1, 4-12 (1995)
DOI: 10.1177/0272989X9501500103
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Med Decis MakingHome page
J. H. Goldberg
Being There Is Important, but Getting There Matters Too: The Role of Path in the Valuation Process
Med Decis Making, July 1, 2006; 26(4): 323 - 337.
[Abstract] [PDF]

Home page
 JCOHome page
P. R. Helft, R. E. Eckles, C. S. Johnson-Calley, and C. K. Daugherty
Use of the Internet to Obtain Cancer Information Among Cancer Patients at an Urban County Hospital
J. Clin. Oncol., August 1, 2005; 23(22): 4954 - 4962.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
D. M. Bravata, L. M. Nelson, A. M. Garber, and M. K. Goldstein
Invariance and Inconsistency in Utility Ratings
Med Decis Making, March 1, 2005; 25(2): 158 - 167.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
S. K. Steginga and S. Occhipinti
The Application of the Heuristic-Systematic Processing Model to Treatment Decision Making about Prostate Cancer
Med Decis Making, November 1, 2004; 24(6): 573 - 583.
[Abstract] [PDF]

Home page
 J. Med. Genet.Home page
E A Lobb, P N Butow, B Meiser, A Barratt, C Gaff, M A Young, J Kirk, M Gattas, M Gleeson, and K Tucker
Women's preferences and consultants' communication of risk in consultations about familial breast cancer: impact on patient outcomes
J. Med. Genet., May 1, 2003; 40(5): e56 - 56.
[Full Text] [PDF]

Home page
 JCOHome page
P. M. Ellis, P. N. Butow, M. H.N. Tattersall, S. M. Dunn, and N. Houssami
Randomized Clinical Trials in Oncology: Understanding and Attitudes Predict Willingness to Participate
J. Clin. Oncol., August 1, 2001; 19(15): 3554 - 3561.
[Abstract] [Full Text] [PDF]

Home page
 Nurs EthicsHome page
C. Sainio, S. Lauri, and E. Eriksson
Cancer Patients' Views and Experiences of Participation in Care and Decision Making
Nursing Ethics, March 1, 2001; 8(2): 97 - 113.
[Abstract] [PDF]

Home page
 J Health PsycholHome page
S. M. Auerbach
Do Patients Want Control over their Own Health Care? A Review of Measures, Findings, and Research Issues
J Health Psychol, March 1, 2001; 6(2): 191 - 203.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
A. Edwards and G. Elwyn
How Should Effectiveness of Risk Communication to Aid Patients' Decisions Be Judged?: A Review of the Literature
Med Decis Making, October 1, 1999; 19(4): 428 - 434.
[Abstract] [PDF]

Home page
 JCOHome page
C. K. Daugherty
Impact of Therapeutic Research on Informed Consent and the Ethics of Clinical Trials: A Medical Oncology Perspective
J. Clin. Oncol., May 1, 1999; 17(5): 1601 - 1601.
[Abstract] [Full Text] [PDF]